Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Current, new, and emerging therapies for managing hyperglycaemia in type 2 diabetes.

× No keyword cloud information.

14 in total

1. Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes.

Authors: Dennis Kim; Leigh MacConell; Dongliang Zhuang; Prajakti A Kothare; Michael Trautmann; Mark Fineman; Kristin Taylor
Journal: Diabetes Care Date: 2007-03-12 Impact factor: 19.112

Review 2. Therapeutic intervention in the GLP-1 pathway in Type 2 diabetes.

Authors: J C Levy
Journal: Diabet Med Date: 2006-03 Impact factor: 4.359

3. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors: William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal: N Engl J Med Date: 2002-02-07 Impact factor: 91.245

4. SIRT1 modulating compounds from high-throughput screening as anti-inflammatory and insulin-sensitizing agents.

Authors: Vasantha M Nayagam; Xukun Wang; Yong Cheng Tan; Anders Poulsen; Kee Chuan Goh; Tony Ng; Haishan Wang; Hong Yan Song; Binhui Ni; Michael Entzeroth; Walter Stünkel
Journal: J Biomol Screen Date: 2006-11-12

5. Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus.

Authors: T Vilsbøll; B Brock; H Perrild; K Levin; H-H Lervang; K Kølendorf; T Krarup; O Schmitz; M Zdravkovic; T Le-Thi; S Madsbad
Journal: Diabet Med Date: 2008-01-14 Impact factor: 4.359

6. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes.

Authors: M Nauck; F Stöckmann; R Ebert; W Creutzfeldt
Journal: Diabetologia Date: 1986-01 Impact factor: 10.122

7. The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study.

Authors: Erland Erdmann; John A Dormandy; Bernard Charbonnel; Massimo Massi-Benedetti; Ian K Moules; Allan M Skene
Journal: J Am Coll Cardiol Date: 2007-04-16 Impact factor: 24.094

8. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors:
Journal: Lancet Date: 1998-09-12 Impact factor: 79.321

9. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.